View Latest Medical and Pharma Bids and Tenders

Advanced Search

Germany human medicine Tenders Contracts and Bids

Find Germany human medicine tenders and government contracts. Search business opportunities for Germany human medicine tenders, Germany generic medicine tenders, Germany antibiotics medicine tenders, Germany homeopathy medicine tenders..

Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Perindopril And Indapamide (Excluding Perindopril As Arginine Salt), Atc C09Ba54 For The Period 01.02.25 - 31.01.27
Country:
Germany
Estimated Cost:
EUR 1
Notice Type:
Tender Notice
Deadline:
04 Dec 2026
Posting Date:
16 Dec 2024
 
 
 
Summary:
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Code Book V For The Active Ingredient Aripiprazole (Excl. Dafo For The Production Of A Dis), (Obo) Atc N05Ax12 For The Period 01.02.2025 - 31.01.2027
Country:
Germany
Estimated Cost:
EUR 1
Notice Type:
Tender Notice
Deadline:
04 Dec 2026
Posting Date:
16 Dec 2024
 
 
 
Summary:
Open House Discount Agreements 2024-14
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
31 Jan 2027
Posting Date:
16 Dec 2024
 
 
 
Summary:
Open Framework Agreement On Drug Discounts Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) With The Option To Join At Any Time, So-Called Approval Model 2025-02" Of The German Pension Insurance Knappschaft-Bahn-See
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
05 Dec 2026
Posting Date:
13 Dec 2024
 
 
 
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Minoxidil (C02Dc01) Within The Framework Of A So-Called Open-House Model.
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Nov 2026
Posting Date:
12 Dec 2024
 
 
 
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pegfilgrastim (L03Aa13) Within The Framework Of A So-Called Open-House Model.
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Nov 2026
Posting Date:
12 Dec 2024
 
 
 
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Acetylsalicylic Acid (B01Ac06) Within The Framework Of A So-Called Open-House Model.
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Nov 2026
Posting Date:
12 Dec 2024
 
 
 
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Dornase Alfa (R05Cb13) Within The Framework Of A So-Called Open-House Model.
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Nov 2026
Posting Date:
12 Dec 2024
 
 
 
Summary:
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Peginterferon Beta-1A (L03Ab13) Within The Framework Of A So-Called Open-House Model.
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Nov 2026
Posting Date:
12 Dec 2024
 
 
 
Summary:
Medicines Containing The Active Ingredient Budesonide (Atc: A07Ea06)
Country:
Germany
 
Notice Type:
Tender Notice
Deadline:
30 Nov 2026
Posting Date:
09 Dec 2024